Skip to main content

The International Journal of Tuberculosis and Lung Disease publishes articles on all aspects of lung health, including public health-related issues such as training programmes, cost-benefit analysis, legislation, epidemiology, intervention studies and health systems research. The IJTLD is dedicated to the continuing education of physicians and health personnel and the dissemination of information on tuberculosis and lung health world-wide.

Certain IJTLD articles are selected for translation into French, Spanish, Chinese or Russian. They are available on the Union website

Publisher: International Union Against Tuberculosis and Lung Disease

More about this publication?
Volume 3, Supplement 3, November 1999

Miscellaneous

Free Content Gianni Acocella [Dedication]
pp. S281-S281(1)
Author: Roscigno, G.

Favourites:
ADD

Free Content Assuring bioavailability of fixed-dose combinations of anti-tuberculosis medications [Scientific Statement]
pp. S282-S283(2)
Author: Official Joint Statement of the International Union Against Tuberculosis and Lung Disease and the World Health Organization

Favourites:
ADD

Free Content Quality assurance: protocol for assessing the rifampicin bioavailability of combined formulations in healthy volunteers [Protocol]
pp. S284-S285(2)
Authors: International Union Against Tuberculosis and Lung Disease; World Health Organization

Favourites:
ADD

Free Content Fixed-dose combination formulations for tuberculosis treatment [Editorial]
pp. S286-S288(3)
Authors: Sbarbaro, John; Blomberg, Bjørn; Chaulet, Pierre

Favourites:
ADD

Review article

Free Content Estimate of the global market for rifampicin-containing fixed-dose combination tablets
pp. S292-S300(9)
Authors: Norval, P.-Y.; Blomberg, B.; Kitler, M. E.; Dye, C.; Spinaci, S.

Favourites:
ADD

Free Content Recent bioequivalence studies on fixed-dose combination anti-tuberculosis drug formulations available on the global market
pp. S309-S316(8)
Authors: Pillai, G.; Fourie, P. B.; Padayatchi, N.; Onyebujoh, P. C.; McIlleron, H.; Smith, P. J.; Gabriels, G.

Favourites:
ADD

Miscellaneous

Free Content Panel Discussion I [Transcription of Panel Discussion]
pp. S317-S321(5)
Authors: Iseman, M D; Fourie, P B; Mitchison, D A; Kaul, C; Wang, J

Favourites:
ADD

Regular Papers

Free Content The development of a standardised screening protocol for the in vivo assessment of rifampicin bioavailability
pp. S329-S335(7)
Authors: McIlleron, H.; Gabriels, G.; Smith, P. J.; Fourie, P. B.; Ellard, G. A.

Favourites:
ADD

Free Content The WHO Simplified Study Protocol in practice: investigation of combined formulations supplied by the WHO
pp. S336-S342(7)
Authors: Panchagnula, R.; Kaur, K. J.; Singh, I.; Kaul, C. L.

Favourites:
ADD

Free Content Detection of substandard fixed-dose combination tuberculosis drugs using thin-layer chromatography
pp. S347-S350(4)
Authors: Kenyon, T. A.; Kenyon, A. S.; Kgarebe, B. V.; Mothibedi, D.; Binkin, N. J.; Layloff, T. P.

Favourites:
ADD

Miscellaneous

Free Content Panel Discussion II [Transcription of Panel Discussion]
pp. S351-S352(2)
Authors: Iseman, M D; Fourie, P B; Mitchison, D A; Kaul, C; Wang, J

Favourites:
ADD

Regular Papers

Free Content Requirements for anti-tuberculosis drug tender requests
pp. S358-S361(4)
Authors: Trébucq, Arnaud; Caudron, J. M.; Pinel, J.

Favourites:
ADD

Free Content Availability of quality fixed-dose combinations for the treatment of tuberculosis: what can we learn from studying the World Health Organization's vaccine model?
pp. S371-S380(10)
Authors: Blomberg, B.; Kitler, M. E.; Milstien, J.; Dellepiane, N.; Fanning, A.; Norval, P. Y.; Spinaci, S.

Favourites:
ADD

Miscellaneous

Free Content Panel Discussion III [Transcription of Panel Discussion]
pp. S381-S387(7)
Authors: Iseman, M D; Spinaci, S; Weil, D; Coulibaly, I M; Cruz, R; Mantala, J

Favourites:
ADD
Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more